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ABSTRACT The effect of L-glutamic acid on the embryolethal and terato- 
genic action of trypan blue was investigated in Wistar albino rats. L-glutamic 
acid was either incorporated into the diet, from gestation day 2 to day 20, or 
suspended in sesame oil and administered by gavage, from gestation day 6 to 
day 10. The day of finding sperm in the vaginal smear was designated day 0 of 
pregnancy. A teratogenic dose of trypan blue was injected a t  day 8 of pregnancy, 
either intraperitoneally (14 mg/kg maternal body weight) or subcutaneously 
(160 mg/kg). The amount of glutamic acid consumed, after the injection of trypan 
blue, ranged from 600 to 1,500 mgiratlday. Pregnancy was terminated at day 20, 
and the fetuses were recovered and examined. Glutamic acid failed consistently 
to protect the rat embryo against the lethal and teratogenic action of trypan 
blue. These results are in contrast to those obtained in mice. The administration 
of sesame oil alone was found to cause embryonic death, but not malformations. 
The disazo dye trypan blue has a long his- 
tory as an experimental teratogen. It was first 
demonstrated to induce malformations in rats 
by Gillman et  al. ('481, and was shown subse- 
quently to produce malformations in a variety 
of animals (review by Beck and Lloyd, '66). 
Very little is known about the mechanism of 
action of trypan blue. A relationship between 
the yolk sac placenta and trypan blue terato- 
genesis was first postulated by Wilson et  al. 
('59). Trypan blue is avidly taken up by cells 
of the visceral endoderm of the rodent yolk sac 
and becomes localized in the supranuclear 
zone of these cells. Only very small amounts 
of the dye reach the embryo (Davis and Gun- 
berg, '68; Davis and Sauter, '77; Dencker, '77). 
Beck e t  al. ('67) postulated that trypan blue 
interfered with the histiotrophic function of 
the yolk sac, and Williams et al. ('76) have 
demonstrated that trypan blue decreases the 
pinocytotic activity of rat yolk sac in vitro. 
Trypan blue also inhibits protein synthesis on 
free and membrane-bound ribosomes in the 
chorioallantoic placenta of mice (Tarachand 
and Eapen, '73). 
Runner ('59) proposed that to be informative 
a teratological experiment should be reversi- 
ble by an antidote. Such an experiment could 
be expected to give insight into the mechanism 
of action of the teratogen. Antimetabolites 
represent compounds that can be used in ter- 
atogen-antiteratogen experiments. There are 
only a few experiments, however, that report 
efforts to find an  antiteratogen to trypan blue. 
In the chick, citric acid has been reported to 
decrease trypan blue-induced mortality and 
malformation (Beaudoin, '68), hyperoxia re- 
portedly eliminates mortality (Hoffman and 
Ramm, '721, and hypothermia and hyperther- 
mia decrease the incidence of induced tail 
defects (Kolesari and Kaplan, '74). Agarwal et  
al. ('60) reported that cortisone acetate offered 
complete protection against trypan blue-in- 
duced cardiac defects in rats. In the mouse, 
Zawoiski ('75) reported that L-glutamic acid 
significantly decreased trypan blue-induced 
resorptions and exencephaly, and L-valine de- 
creased trypan blue-induced resorptions. 
Exencephaly is the most frequently seen 
malformation in rats in my colony, following 
trypan blue treatment. It was decided, there- 
fore, to test the reported protective effect of L- 
glutamic acid in these rats. 
MATERIALS AND METHODS 
Virgin female Wistar-derived rats from my 
colony were used. The animals were fed Tek- 
lad Rat Diet (Teklad Mills, Winfield, Iowa) ad 
libitum with weekly supplemental feedings of 
lettuce. The day of finding sperm in the vagi- 
nal smear was designated day 0 of pregnancy. 
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In one series of experiments, L-glutamic 
acid (Sigma Chemical Co., Cleveland, Ohio) 
was mixed thoroughly with finely powdered 
rat chow at 1:20 or 1:12 and the mixture was 
fed from day 2 to day 20 of gestation. Food 
consumption was measured daily. In a second 
series of experiments, L-glutamic acid was 
suspended in sesame oil and administered by 
gavage from day 6 to day 10 of pregnancy. 
One-half the daily dose was given in 2 ml of 
sesame oil a t  9 A.M. and the remainder was 
given at 3 P.M. of the same day. The total daily 
dose was 600 mg/animal. The gavage dose was 
selected to be the same dose (601 mg/day) used 
by Zawoiski ('75) in mice. 
A teratogenic dose of trypan blue' was in- 
jected at  gestation day 8, either intraperito- 
neally (ip) (14 mg/kg maternal body weight) 
or subcutaneously (sc) (160 mg/kg). Four types 
of controls were used: (1) trypan blue, (2) 
glutamic acid in the diet, (3) glutamic acid by 
gavage, and (4) sesame oil by gavage. Preg- 
nancy was terminated a t  day 20. The resorp- 
tion sites were counted and the fetuses were 
recovered, weighed, and fixed in  Bouin's fluid 
for subsequent examination. Placentas also 
were examined and weighed. 
RESULTS 
Table 1 summarizes the results of this ex- 
periment. The administration of glutamic acid 
failed consistently to protect the embryo 
against the lethal and teratogenic action of 
trypan blue. In fact, the combined treatment 
produced a slight, although not statistically 
significant, increase in the incidence of resorp- 
tions and malformations over that following 
trypan blue treatment alone. There was no 
difference in the results when the glutamic 
acid concentration in the diet was increased 
from 1:20 to 1:12; therefore, these results are 
combined in Table 1. In the 20 animals receiv- 
ing glutamic acid together with trypan blue, 
91% (SD 2 11) of all implantation sites were 
affected adversely (resorbed or malformed). 
This compares with 76% (SD 2 20) of all 
implantation sites affected by trypan blue 
treatment alone. Because there was no evi- 
dence or suggestion of protection in any of the 
experiments performed, the use of additional 
animals was deemed unnecessary. 
The results of this experiment suggest that  
sesame oil, in itself, may be embryolethal, but 
not teratogenic. The incidence of resorptions 
is similar when sesame oil is administered 
alone and when it is used as the vehicle for 
glutamic acid (Table 1). In both experiments, 
the number of resorptions is higher than the 
incidence (5.3%) of resorption seen in untreat- 
ed controls in my colony during the past 20 
years. A statistical comparison (x2) of the 
number of resorptions following sesame oil 
alone with the number of resorptions following 
glutamic acid alone (in diet) yields a P value 
of 0.04. The percentage of trypan blue-induced 
malformed fetuses in the present study (60%) 
is similar to the percentage of malformed 
fetuses observed in the cumulative data over 
the 20-year period (57%). 
In this experiment, rats ate 22.6 k 2.7 gm/ 
day of powdered rat food containing either 
1:20 or 1:12 glutamic acid prior to receiving 
trypan blue intraperitoneally. After injection, 
the rats consumed 20.4 2 3.3 gm of food daily. 
The average intake of glutamic acid was 1.5 
2 0.32 gmlday prior to trypan blue injection 
and 1.3 2 0.35 gm/day after injection. Rats 
receiving trypan blue subcutaneously ate 21.2 
t 4.0 gmlday of powdered rat chow containing 
1:12 glutamic acid prior to the injection and 
18.5 2 3.1 gm/day following the injection. The 
corresponding amounts of glutamic acid in- 
gested were 1.7 * 0.36 gm/day and 1.5 +- 0.24 
gmlday respectively. Trypan blue treatment 
resulted in a decrease in glutamic acid con- 
sumption of approximately 13%. The control 
rats receiving glutamic acid in their diet ate 
an  average of 23.9 2 3.3 gm of food per day 
throughout pregnancy with the resultant in- 
take of 2.0 -t 0.26 gm glutamic acid daily. The 
amount of glutamic acid administered by gav- 
age (600 mgiratlday) was the same amount 
consumed by Zawoiski's mice ('75). In the 
present experiment, however, neither 600 mgi 
day of glutamic acid by gavage, nor 1,500 mg/ 
day of glutamic acid consumed in the diet was 
able to protect the rat embryo against the 
lethal and teratogenic action of trypan blue. 
Table 2 lists the types of malformations 
induced in this experiment. In spite of an  
apparent increase in frequency following the 
combined treatments, there are no statistical- 
ly significant differences between the numbers 
of malformations induced by trypan blue alone 
and the number induced by trypan blue in 
combination with glutamic acid. Exencephaly 
was always the most frequently seen malfor- 
mation, followed by absent eyelid and ano- 
phthalamia/microphthalamia. 
'Trypan blue (Direct Blue 14) color index 23850, Lot B-430, 
Matheson, Coleman and Bell, Cincinnati, Ohio. This is from the same 
lot as the dye used by Zawoiski ("75). 
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number of embryonic resorptions -16.2% and 
15.6%, respectively. In a recent experiment 
with PBB, sesame oil was used as the vehicle 
for gavage administration (Beaudoin, '77). 
Nine pregnant rats received sesame oil by 
gavage at day 11, 12, and 13 of gestation. Of 
109 implantation sites, 10% were resorbed 
DISCUSSION 
The analysis of the results in this experi- 
ment revealed that there was a marked in- 
crease in the number of embryos dying follow- 
ing the use of sesame oil. The administration 
of sesame oil either alone or as the vehicle for 
glutamic acid resulted in an almost identical 
TABLE 1 .  The effect of L-glutamic acid on the embryolethal and temtogenic action of trypan blue 
Treatment 
Survivors Fetal 
No. females No. implan- Resorbed malformed weight (gm) 
Dosaee treated tation sites (%) (%) mean 2 SD 
Glutamic acid in diet 1 : 20 and 1 : 12, 
(1,300-1,500 mg/day) 
14 mg/kg, day 8 
1 : 12, day 2-20 
160 mgkg, day 8 
600 mg/day, 
14 mg/kg, day 8 
600 mg/day, 
160 mgikg, day 8 
91 63.7 75.7 3.20 2 0.39 plus day 2-20 
trypan blue ip' 
Glutamic acid in  diet 
trypan blue sc2 
Glutamic acid by gavage 
trypan blue ip 
Glutamic acid by gavage 
trypan blue sc 
Glutamic acid in diet 1 : 12, day 2-20 4 61 4.9 0 3.51 2 0.02 
plus (1,500 mg/day) 5 61 55.7 63.0 3.26 2 0.28 
plus day 6-10 4 42 61.9 93.7 3.15 2 0.44 
plus day 6-10 5 56 48.2 79.3 3.44 ? 0.18 
Glutamic acid by gavage 600 mgiday, 
day 6-10 
4 64 15.6 0 3.96 2 0.02 
Sesame Oil 4 mYday, day 6-10 5 68 16.2 0 3.97 2 0.04 
Trypan blue ip 14 mdkg 6 69 39.1 60.0 3.34 2 0.38 
' Intraperitoneally. 
* Subcutaneously. 
TABLE 2. Incidence of malformations following treatment with glutamic acid and trypan blue ' 
Anophthalmid 
Treatment Exencephaly microphthalmia Absent eyelid Hydrocephalus Other* 
Glutamic acid in diet 
trypan blue ip 
Glutamic acid in diet 
trypan blue sc 
plus 76.0 36.0 56.0 4.0 16.0 
plus 70.5 35.3 47.0 5.9 17.6 
Glutamic acid by gavage 
trypan blue ip 
plus 73.3 46.7 40.0 0 20.0 
Glutamic acid by gavage 
trypan blue sc 
plus 87.0 17.4 56.5 4.3 8.7 
Trypan blue ip 64.0 28.0 48.0 16.0 8.0 
'Percentage of total number of survivors malformed. 
* Encephalomeningocele and cranial blister. 
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and one fetus, from a mother treated at  day 
12, was found to be lacking the digits on all 
four paws. There was no effect on maternal, 
fetal, or placental weight. The spontaneous 
incidence of resorption in the rats used in my 
laboratory is 5.3%, based on 20 years cumu- 
lative data. A similar increase (10-25%) in 
resorption following the subcutaneous injec- 
tion of sesame oil is reported by Palazzolo et 
al. ('72). The results of these experiments 
suggest that sesame oil can be lethal to the 
embryo during the early stages of rat embry- 
ogenesis. Further experimentation with other 
doses and other treatment days during gesta- 
tion will be necessary in order to determine 
whether or not sesame oil also possesses ter- 
atogenic activity. 
Zawoiski ('75) reported L-glutamic acid to 
be effective in reducing the number of trypan 
blue-induced resorptions and exencephalic fe- 
tuses in mice. L-glutamic acid was not effec- 
tive as an antilethal or antiteratogenic agent 
in the present experiment. The reason why 
the results in the two experiments differ is 
not known. Each experiment contained ani- 
mals injected with identical subcutaneous dos- 
es of trypan blue and receiving the same 
amount of glutamic acid. The present experi- 
ment, in addition, contained rats receiving 
intraperitoneal injections of trypan blue, gav- 
age feedings of glutamic acid, and higher 
dosages in the diet than in the diet of the 
mice. Not one of the present experiments, 
however, gave any indication of a reduction 
in the number of trypan blue-induced resorp- 
tions or exencephalic fetuses. Actually a 
slight, although not statistically significant, 
increase in both resorptions and exencephalic 
fetuses occurred. Experiments with L-valine, 
reported to protect against trypan blue-in- 
duced resorptions (Zawoiski, '751, gave results 
similar to those of the experiments with L- 
glutamic acid. Combined treatment of preg- 
nant rats with trypan blue and valine during 
the period of organogenesis resulted in the 
resorption of 67.W0 of 262 implantation sites, 
and in malformations in 69.M of the survi- 
vors: the majority with exencephaly (Beau- 
doin, unpublished). 
Glutamic acid is a nonessential amino acid 
that can be made via transamination from 
aketoglutaric acid. In all species aketoglutar- 
ate is reported to be metabolically always 
present (White et al., '73). Glutamic acid is 
involved in many metabolic reactions, none of 
which suggests an obvious role in teratoge- 
nesis but several of which could be postulated 
to be involved in teratogenesis. Zawoiski ('77) 
concluded that the antiteratogenic activity of 
glutamic acid in mice was not due t o  its 
biotransformation into L-alanine, L-aspartic 
acid, or one of their metabolites. 
The most apparent difference between Za- 
woiski's experiment and this experiment is 
the animal used (mouse and rat). There are 
differences in metabolic rates and in daily 
food consumption between the rat and the 
mouse, but what influence these differences 
may have on the outcome of the experiments 
is not known. It is accepted in teratology that 
species differences exist in the response to  
treatment with the same teratogen and at the 
same dose. The same dose of trypan blue, 
moreover, has been shown to induce different 
teratogenic responses in different strains of 
rats (Gunberg, '58). There are more similari- 
ties than dissimilarities between the present 
experiment and the experiment performed by 
Zawoiski. Glutamic acid metabolism is pre- 
sumably the same in both the mouse and the 
rat (White et al., '73). Both animals are ro- 
dents with a yolk sac placenta, which is sus- 
pected of playing a role in trypan blue tera- 
togenesis. The dye accumulates in the visceral 
endodermal cells of the yolk sac in both the 
rat (Wilson et al., '59) and the mouse (Green- 
house et al., '69), and the dye reduces acid 
phosphatase activity in these same cells in the 
rat (Beck et al., '67) and the mouse (Green- 
house et al., '69). Dencker ('77) has shown that 
trypan blue can be detected in the yolk sac 
fluid and in the wall of the embryonic gut in 
both rat and mouse embryos. The same dos- 
age, route of administration, and time in ges- 
tation were used in each experiment, and 
similar malformations were induced by trypan 
blue in the rat and in the mouse fetus. The 
trypan blue used by Zawoiski and in the 
present experiment was not only from the 
same manufacturer, but from the same lot as 
well. At this time, no satisfactory explanation 
can be given for the discrepancy in the results. 
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